Live from the NIH registry
Studies recruiting near Dayton right now
Top 25 of 310 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10119, Centerville, OH — Centerville, Ohio (10.7 mi)
· Sponsor: Colorado Prevention Center
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Hometown Urgent Care and Research - Dayton — Dayton, Ohio (1.6 mi)
· Sponsor: Crystalys Therapeutics
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
DSI Research, LLC d/b/a ObjectiveHealth Clinical Research - Springboro — Springboro, Ohio (15.9 mi)
· Sponsor: Eli Lilly and Company
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Good Samaritan Hospital - Dayton — Dayton, Ohio (1.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Arthritis and Rheumatology of Southwest Ohio — Liberty Township, Ohio (28.1 mi)
· Sponsor: University of Alabama at Birmingham
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
Actinic Keratoses, Aging
N/A
Interventional 80 participants sought
Wright State Physicians — Fairborn, Ohio (10.0 mi)
· Sponsor: Wright State University
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Dayton Physician LLC-Miami Valley Hospital North — Dayton, Ohio (1.6 mi)
· Sponsor: SWOG Cancer Research Network
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC)
Phase 1, Phase 2
Interventional 270 participants sought
Xencor Investigative Site — Beavercreek, Ohio (8.8 mi)
· Sponsor: Xencor, Inc.
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 140 participants sought
Kettering Medical Center /ID# 274365 — Kettering, Ohio (6.5 mi)
· Sponsor: AbbVie
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Heart House Research Foundation LLC — Springfield, Ohio (23.0 mi)
· Sponsor: Duke University
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: NRG Oncology
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 7081 — Dayton, Ohio (1.6 mi)
· Sponsor: Galderma R&D
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Good Samaritan Hospital - Dayton — Dayton, Ohio (1.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Dayton Physician's Network — Dayton, Ohio (1.6 mi)
· Sponsor: Amgen
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Miami Valley Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Kettering Health — Kettering, Ohio (6.5 mi)
· Sponsor: American Society of Clinical Oncology
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Premier Blood and Cancer Center — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
META Medical Research Institute — Dayton, Ohio (1.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Phase 3
Interventional 723 participants sought
Dayton Center for Neurological Disorders — Centerville, Ohio (10.7 mi)
· Sponsor: Pfizer
Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness
Pulmonary Embolism Acute
N/A
Interventional 39 participants sought
Kettering Health — Kettering, Ohio (6.5 mi)
· Sponsor: Angiodynamics, Inc.
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Dayton Children's Hospital — Dayton, Ohio (1.6 mi)
· Sponsor: National Cancer Institute (NCI)